Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAI-mediated inhibition of tumor necrosis factor α-related conditions

RNAI-mediated inhibition of tumor necrosis factor α-related conditions

US Patent 7732421 · Granted Jun 8, 2010

Estimated economic value: $101,661,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Back interface for rack shelf2025
Method for treating pruritus2025
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2023
Fixation members, assemblies, and related systems and methods2023
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2022
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)2021
Intranasal stimulation for treatment of meibomian gland disease and blepharitis2021
Transferrin/transferrin receptor-mediated siRNA delivery2018
Interfering RNA delivery system and uses thereof2018
Interfering RNA delivery system and uses thereof2017